Abstract
The current assessment of corneal vascularisation (CV) relies on slit-lamp examination, which may be subjective. Dye-based angiographies, like indocyanine green angiography (ICGA), allows for good visualisation of anterior segment blood vessels. However, ICGA is invasive and can be associated with systemic adverse effects. Anterior segment optical coherence tomography angiography (AS-OCTA) is a non-invasive tool that has been shown to successfully delineate CV. However, there are no previous studies that have reported if AS-OCTA can determine CV stage and activity. We used an established CV model in rabbits to examine serial AS-OCTA scans of CV development and regression following treatment with anti-vascular endothelial growth factor. We compared AS-OCTA derived vascular measurements to that of ICGA determined vessel leakage and CV staging. Our results showed that AS-OCTA vessel densities and vessel branch area significantly correlated with the severity of CV based on ICGA (all p ≤ 0.05). We also found that AS-OCTA vessel densities correlated with ICGA vessel leakage time, following an inverse linear relationship (r2 = − 0.726, p < 0.01). Changes in aqueous levels of CXCL-12 and PIGF cytokines significantly correlated with AS-OCTA vessel densities (r2 = 0.736 and r2 = 0.731 respectively, all p < 0.05). In summary, we found that AS-OCTA derived vessel parameters may be useful for assessing CV severity, while vessel density correlates with CV activity and leakage. Thus, our pilot animal model study suggests that AS-OCTA may be a useful non-invasive imaging tool to provide objective assessment of CV to examine progression or response in treatment, which requires confirmation in clinical studies.
Highlights
The current assessment of corneal vascularisation (CV) relies on slit-lamp examination, which may be subjective
Anterior segment optical coherence tomography angiography (AS-OCT angiography (OCTA)) vessel densities were significantly higher in the first and second weeks following placement of cornea sutures (30.9 ± 3.4% and 22.2 ± 2.4% respectively), compared to the baseline visit (6.5 ± 2.5%) (p < 0.01)
Eyes in the treatment group exhibited regression in corneal vascularization as demonstrated by a reduction in AS-OCTA vessel densities at one week (24.6 ± 3.4%, p = 0.008) and two weeks (25.7 ± 2.47%, p = 0.003) following sub-conjunctival aflibercept injections, compared to pre-injection measurements (30.9 ± 3.4%) (Figs. 3, 4A)
Summary
The current assessment of corneal vascularisation (CV) relies on slit-lamp examination, which may be subjective. We found that AS-OCTA derived vessel parameters may be useful for assessing CV severity, while vessel density correlates with CV activity and leakage. Our pilot animal model study suggests that AS-OCTA may be a useful non-invasive imaging tool to provide objective assessment of CV to examine progression or response in treatment, which requires confirmation in clinical studies. Slit lamp photography is the most widely used clinical imaging technique to visualize blood vessels in the anterior segment and ocular surface, such as the cornea, limbus, and conjunctiva[4]. Indocyanine green angiography (ICGA), a dye-based angiography, is another imaging technique that provides good visualisation of blood vessels in the anterior s egment[6]. There are currently no studies that have examined the correlation of OCTA vessel parameters with the severity of corneal vascularisation and vessel leakage[16]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.